735 Peripheral and tissue persistence of agenT-797, an allogeneic iNKT cell-based cell therapy for the treatment of cancer

• Rachel E Sanborn,
• Trisha M Wise-Draper,
• Marc Van Dijk,
• Breelyn Wilky,
• Anthony El-Khoueiry,
• John Hamm,
• Benjamin Garmezy,
• Benedito Carneiro,
• Jamie Moon,
• Sue Ryu,
• Irene R Ramos,
• Marco A Purbhoo,
• Dave SB Hoon

Affiliations

Rachel E Sanborn

1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA

Trisha M Wise-Draper

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

Marc Van Dijk

MNK Therapeutics, Lexington, MA, USA

Breelyn Wilky

Medicine, University of Colorado Denver Health Sciences Center, Aurora, Colorado, USA

Anthony El-Khoueiry

6USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA

John Hamm

11Norton Healthcare, Louisville, KY, USA

Benjamin Garmezy

6Sarah Cannon Cancer Institute Nashville, Nashville, TN, USA

Benedito Carneiro

2Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Jamie Moon

1Saint John’s Cancer Institute, Santa Monica, CA, USA

Sue Ryu

1Saint John’s Cancer Institute, Santa Monica, CA, USA

Irene R Ramos

1Saint John’s Cancer Institute, Santa Monica, CA, USA

Marco A Purbhoo

9MiNK Therapeutics, Lexington, MA, USA

Dave SB Hoon

1Saint John’s Cancer Institute, Santa Monica, CA, USA